by synergycap1 | Aug 28, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Grow, Working Capital
You can develop them as systematically as you would the muscles in your body.
by synergycap1 | Aug 28, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Wire, Working Capital
German students took home first prize at SpaceX’s Hyperloop competition that ran this weekend. WARR Hyperloop, a team composed of students from Technical University of Munich, clinched the win after its pod reached a top speed of 324 kilometers per hour...
by synergycap1 | Aug 28, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
Lines are stretching out the door for the grocery stores that have started to reopen in Texas as the remnants of Hurricane Harvey continue to soak the region. The hurricane dumped multiple feet of rain on the area over the weekend. The flooding could continue during...
by synergycap1 | Aug 28, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
And Williams would know — she spent 26 years in the FBI investigating economic crimes, including a $350 million Ponzi scheme. (That case ended in a 12-year prison sentence.) “With a gun you can steal hundreds. With a pen you can steal millions,” she...
by synergycap1 | Aug 28, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Startup, Working Capital
What’s your step-by-step recipe to get from $1-100M in B2B SaaS global sales? originally appeared on Quora – the place to gain and share knowledge, empowering people to learn from others and better understand the world. Answer by Paul Holland, General...
by synergycap1 | Aug 28, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Food and Drug Administration, Non-Bank Loans, Regulation and Deregulation of Industry, Stem Cells, Working Capital
The agency reported actions against a biotech company and two large stem cell clinics over unapproved treatments, a move it said was necessary to make way for speedier approval of legitimate therapies.
